Document is current

Any future updates will be listed below

Combined amylin analogue and GLP1 receptor agonist therapies are highly promising for weight loss

Crossref DOI link: https://doi.org/10.1038/s41574-025-01156-2

Published Online: 2025-07-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark